StockData
Rezolute, Inc. logo

Rezolute, Inc. (RZLT) stock

RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$4.01+0.43 (+12.15%)

Close on Nov 17, 2026Market cap $388.34MP/E –Yield –

Rezolute ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Rezolute's ebitda for the twelve months ending Sep 30, 2026 was -$82.50M. For fiscal 2026 it was -$82.94M. The highest annual figure on record is -$5.16M in fiscal 2014.

Annual ebitda

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$82.94M–
FY2025Jun 30, 2025-$79.86M–
FY2024Jun 30, 2024-$70.39M–
FY2023Jun 30, 2023-$55.96M–
FY2022Jun 30, 2022-$41.83M–
FY2021Jun 30, 2021-$22.88M–
FY2020Jun 30, 2020-$20.50M–
FY2019Jun 30, 2019-$25.90M–
FY2018Jun 30, 2018-$27.67M–
FY2014Jun 30, 2014-$5.16M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026-$19.38M–
Q4 FY2026CQ2 2026Jun 30, 2026-$21.55M–
Q3 FY2026CQ1 2026Mar 31, 2026-$17.36M–
Q2 FY2026CQ4 2025Dec 31, 2025-$24.21M–
Q1 FY2026CQ3 2025Sep 30, 2025-$19.81M–
Q4 FY2025CQ2 2025Jun 30, 2025-$25.84M–
Q3 FY2025CQ1 2025Mar 31, 2025-$20.02M–
Q2 FY2025CQ4 2024Dec 31, 2024-$17.07M–
Q1 FY2025CQ3 2024Sep 30, 2024-$16.93M–
Q4 FY2024CQ2 2024Jun 30, 2024-$23.10M–
Q3 FY2024CQ1 2024Mar 31, 2024-$16.20M–
Q2 FY2024CQ4 2023Dec 31, 2023-$15.18M–
Q1 FY2024CQ3 2023Sep 30, 2023-$15.90M–
Q4 FY2023CQ2 2023Jun 30, 2023-$14.23M–
Q3 FY2023CQ1 2023Mar 31, 2023-$17.13M–
Q2 FY2023CQ4 2022Dec 31, 2022-$14.39M–
Q1 FY2023CQ3 2022Sep 30, 2022-$10.22M–
Q4 FY2022CQ2 2022Jun 30, 2022-$11.30M–
Q3 FY2022CQ1 2022Mar 31, 2022-$10.75M–
Q2 FY2022CQ4 2021Dec 31, 2021-$12.15M–
Q1 FY2022CQ3 2021Sep 30, 2021-$7.64M–
Q4 FY2021CQ2 2021Jun 30, 2021-$6.63M–
Q3 FY2021CQ1 2021Mar 31, 2021-$5.48M–
Q2 FY2021CQ4 2020Dec 31, 2020-$7.15M–
Q1 FY2021CQ3 2020Sep 30, 2020-$3.62M–
Q4 FY2020CQ2 2020Jun 30, 2020-$3.55M–
Q3 FY2020CQ1 2020Mar 31, 2020-$5.07M–
Q2 FY2020CQ4 2019Dec 31, 2019-$6.72M–
Q1 FY2020CQ3 2019Sep 30, 2019-$5.17M–
Q4 FY2018CQ2 2018Jun 30, 2018-$11.05M–
Q3 FY2018CQ1 2018Mar 31, 2018-$4.69M–
Q2 FY2018CQ4 2017Dec 31, 2017-$5.48M–

More Rezolute figures

See a number that looks wrong?